Mednet Logo
SpecialtiesNephrology
Nephrology

Nephrology

Clinical discussions on kidney disease management, dialysis, transplantation, and electrolyte disorders.

Recent Discussions

What is your preferred management approach for scleroderma renal crisis in a patient with a history of anaphylaxis to ACE inhibitors?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Yale School of Medicine

The important thing is to lower the BP regardless of the how. ACE I were the first medication to show survival benefit in patients with scleroderma renal crisis so they have become the treatment mainstay. Time is kidney so the best treatment is to lower the BP with whatever BP lowering medication yo...

How do you approach selecting a dialysis modality for a patient with advanced CKD who is interested in home therapy but has a history of medication non-adherence and poor attendance at clinic appointments?

2 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

Good question. I would like to give them a chance at home dialysis before declaring that they are not candidates but I think it should be evaluated on a case by case basis.

Do you still use the urinary anion gap to estimate renal ammonium excretion in patients with a non-anion gap metabolic acidosis, given its limitations?

3
6 Answers

Mednet Member
Mednet Member
Nephrology · Rush Medical College

Yes, I do, but especially as a teaching tool to help understand the make-up of urine in different clinical scenarios. Of course, a urine NH4+ would make this all so much easier, but I believe that the UAG is usually still of value in the evaluation of a NAGMA. The Achilles heel of it, of course, is ...

Do you temporarily hold ESAs for your patients with kidney disease who have an upcoming surgical procedure with the goal of reducing the risk for DVTs?

1
3 Answers

Mednet Member
Mednet Member
Nephrology · Penn Medicine Cherry Hill

I do not routinely recommend this. I think the risk is very small given modern use of ESAs and thromboprophylaxis.

How do you clinically distinguish between pericardial effusion from volume overload versus uremic pericarditis in advanced CKD?

1 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

I don't think volume overload by itself can lead to pericardial effusion; rather, there has to be some form of pericardial irritation. I wonder if fluid overload would make the pericardial effusion worse, which is likely the case. Patients on dialysis, if they have pericardial effusion, I would auto...

Would you start allopurinol for a patient with uric acid kidney stones who does not have hyperuricemia or hyperuricosuria?

1
2 Answers

Mednet Member
Mednet Member
Nephrology · Mayo Clinic

Definitely not! The main risk factor for uric acid kidney stones is neither hyperuricemia nor hyperuricosuria; it is hyperaciduria. Typically uric acid stone formers have a urine pH below 5.8. Raising urine pH into the mid 6s will not only stop new stone formation and existing stone growth; it will ...

Do you prefer allopurinol or febuxostat for patients with chronic kidney disease who are receiving treatment for asymptomatic hyperuricemia?

3
4 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

Allopurinol. For my Asian and sometimes African American patients, I consider HLA testing to make sure they are not at risk for allopurinol hypersensitivity. In which case, I will prescribe febuxostat. Most often, I find the insurance will not even cover febuxostat unless I have tried allopurinol fi...

Under what circumstances would you consider doing a furosemide stress test in the workup of AKI?

1 Answers

Mednet Member
Mednet Member
Nephrology · UCLA

Furosemide stress test may be performed early in the course of Stage 1 or 2 AKI to evaluate the likelihood of progression to Stage 3 AKI or the need for renal replacement therapy. A urine output of <200 ml over 2 hours after furosemide administration is predictive of progression to Stage 3 AKI and t...

Do you use a profile with high ultrafiltration rates interrupted by UF pauses to manage ESKD patients prone to intradialytic hypotension?

1 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

After exhausting lowering the dialysis bath temperature, extending the time of dialysis (including extra treatments), pure ultrafiltration treatment, and I have tried the UF profile options with varying success.

Would you refer an ESKD patient with an identified living donor for AV access placement if kidney transplantation is anticipated in 4 months?

1 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

Good question. I would not because it seems like it would only be a few months that the patient would be able to use the fistula, and I would spare them the surgery. One can make an argument, though, to place one as it may be needed if the transplant fails also. If there is a way one can move up the...